海外規制機関 医薬品安全性情報 (URL)
NIHS 医薬品安全性情報 (隔週報)Vol.15 No.12 2017/06/15 (pdf)
Richardson JL et al.: “Pregnancy outcomes after maternal varenicline use; analysis of surveillance data collected by the European Network of Teratology Information Services.”, Reproductive Toxicology, 67, 26-34 (2017). PMID: 27851994 DOI: 10.1016/j.reprotox.2016.11.010
バレニクリン酒石酸塩(チャンピックス錠)
Damkier P et al.: “Changing of the guards: EMA warning on paternal use of mycophenolate mofetil: An unnecessary and insufficiently substantiated precaution.”, Birth Defects Research Part A Clinical and Molecular Teratology, 106 (10), 860-861 (2016). PMID: 27678452 DOI: 10.1002/bdra.23556
ミコフェノール酸 モフェチル(セルセプトカプセル/懸濁用散)
Winterfeld U et al.: “Pregnancy outcome following maternal exposure to pregabalin may call for concern.”, Neurology, 86 (24), 2251-2257 (2016). PMID: 27194385 DOI: 10.1212/WNL.0000000000002767
プレガバリン(リリカOD錠)
Weber-Schoendorfer C et al.: “Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study.”, British Journal of Clinical Pharmacology, 80 (4), 727-739 (2015). PMID: 25808588 PMCID: PMC4594709 DOI: 10.1111/bcp.12642
インフリキシマブ(遺伝子組換え)(レミケード点滴静注用)
エタネルセプト(遺伝子組換え)(エンブレル皮下注)
アダリムマブ(遺伝子組換え)(ヒュミラ皮下注)
ゴリムマブ(遺伝子組換え)(シンポニー皮下注)
セルトリズマブ ペゴル(遺伝子組換え)(シムジア皮下注)
Winterfeld U et al.: “Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study.”, Journal of Clinical Psychopharmacology, 35 (3), 250-259 (2015). PMID: 25830592 DOI: 10.1097/JCP.0000000000000309
ミルタザピン(リフレックス錠/レメロン錠)
Weber-Schoendorfer C et al.: “Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study.”, Arthritis Rheumatology, 66 (5), 1101-1110 (2014). PMID: 24470106 DOI: 10.1002/art.38368
メトトレキサート(メソトレキセート錠)